BNTCBenitec Biopharma Inc
BNTC
Benitec Biopharma Inc6,356
Mkt Cap
$459.85MVolume
306,750.0052W High
$17.1552W Low
$9.70PE Ratio
-13.51BNTC Fundamentals
Price
$13.58Prev Close
$13.18Open
$13.2650D MA
$14.24Beta
0.43Avg. Volume
348,855.53EPS (Annual)
-$1.05P/B
3.81Rev/Employee
$0.00Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know
The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·1d ago
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·3d ago
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·3d ago
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·3d ago
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·3d ago
Franklin Resources Inc. Cuts Stake in Benitec Biopharma Limited $BNTC
Franklin Resources Inc. lowered its stake in shares of Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) by 5.6% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·8d ago
HC Wainwright Has Optimistic Outlook of BNTC FY2026 Earnings
Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Equities researchers at HC Wainwright boosted their FY2026 EPS estimates for shares of Benitec Biopharma in a research report issued to clients...
MarketBeat·9d ago
Benitec Biopharma (NASDAQ:BNTC) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Benitec Biopharma from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·14d ago
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Rating of "Moderate Buy" from Brokerages
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the company, Marketbeat...
MarketBeat·16d ago
Q1 Earnings Estimate for BNTC Issued By Leerink Partnrs
Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Equities researchers at Leerink Partnrs lowered their Q1 2026 earnings estimates for Benitec Biopharma in a report issued on Monday, November...
MarketBeat·22d ago